Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-03 Purchase |
2023-01-04 08:30 am |
Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director |
10,000 | $0 | $0 | 15,000 (Direct) |
View |
| 2021-06-18 Purchase |
2021-06-21 11:03 am |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
8,000 | $4.75 | $38,000 | 30,000 (Direct) |
View |
| 2021-04-26 Purchase |
2021-04-27 4:02 pm |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
12,000 | $5 | $60,000 | 22,000 (Direct) |
View |
| 2020-04-30 Purchase |
2020-05-04 2:18 pm |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
10,000 | $6 | $60,000 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-25 Option Award |
2025-02-25 9:30 pm |
N/A 2035-02-25 |
Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:19 pm |
N/A 2035-02-17 |
BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer |
170,000 | $0 | 170,000 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 9:31 pm |
2026-01-01 2035-01-01 |
Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director |
5,000 | $0 | 5,000 (Direct) |
View |
Ownership |
2024-09-25 4:45 pm |
N/A N/A |
BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer |
0 | $0 | 270,326 (Direct) |
View |
| 2024-06-24 Option Award |
2024-06-26 9:30 pm |
N/A 2034-06-24 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-19 6:30 pm |
2025-01-01 2034-01-01 |
Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-26 4:38 pm |
N/A 2033-06-23 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
10,500 | $0 | 10,500 (Direct) |
View |
Ownership |
2022-12-28 8:38 pm |
2021-04-01 2031-03-30 |
Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director |
0 | $0 | 17,557 (Direct) |
View |
| 2022-09-20 Option Award |
2022-09-22 4:10 pm |
N/A 2032-09-20 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-12 5:00 pm |
N/A 2032-09-09 |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
37,600 | $0 | 37,600 (Direct) |
View |
| 2021-08-19 Option Award |
2021-09-17 4:17 pm |
N/A 2031-08-19 |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
38,135 | $0 | 38,135 (Direct) |
View |
Ownership |
2021-03-17 8:43 pm |
N/A 2031-01-22 |
Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director |
0 | $0 | 10,000 (Direct) |
View |
| 2020-09-09 Option Award |
2020-09-11 5:20 pm |
N/A 2030-09-09 |
NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director |
14,634 | $0 | 14,634 (Direct) |
View |